Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 6 pseudogene 3 (SLC25A6P3)
- Target
- SLC25A6P3
- Molecular classification
- Pseudogene of a mitochondrial transporter (specifically, the ADP/ATP translocator), Pseudogene
01
Overview
SLC25A6P3 stands for solute carrier family 25 member 6 pseudogene 3, and it is a non-functional human pseudogene related to the active mitochondrial ADP/ATP translocator SLC25A6. Unlike SLC25A6, which is involved in mitochondrial energy exchange and apoptosis, SLC25A6P3 does not encode a protein and has no known biological, disease, or therapeutic roles[1][2][4][6]. The designation as a pseudogene indicates it is a genomic remnant, possibly relevant only for evolutionary, genomic structure, or regulatory studies—not as a molecular target for therapy. References to it as a receptor, transporter, or therapeutic target are inaccurate.
- Other names
- SLC25A6P3Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 pseudogene 3
02
Mechanism of action
No mechanisms of drug action are attributed to SLC25A6P3, as it does not produce a therapeutic target
03
Biological functions
No direct biological functionNo biological activity
04
Disease associations
No attributed disease rolesNon-coding gene
Beyond the preview
Go deeper on Solute carrier family 25 member 6 pseudogene 3 (SLC25A6P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solute carrier family 25 member 6 pseudogene 3 (SLC25A6P3).